| Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA DA Braasch, DR Corey Chemistry & biology 8 (1), 1-7, 2001 | 905 | 2001 |
| Non-coding RNAs as drug targets M Matsui, DR Corey Nature reviews Drug discovery 16 (3), 167-179, 2017 | 886 | 2017 |
| RNA interference in mammalian cells by chemically-modified RNA DA Braasch, S Jensen, Y Liu, K Kaur, K Arar, MA White, DR Corey Biochemistry 42 (26), 7967-7975, 2003 | 796 | 2003 |
| Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death BS Herbert, AE Pitts, SI Baker, SE Hamilton, WE Wright, JW Shay, ... Proceedings of the National Academy of Sciences 96 (25), 14276-14281, 1999 | 757 | 1999 |
| Activating gene expression in mammalian cells with promoter-targeted duplex RNAs BA Janowski, ST Younger, DB Hardy, R Ram, KE Huffman, DR Corey Nature chemical biology 3 (3), 166-173, 2007 | 637 | 2007 |
| Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs X Shen, DR Corey Nucleic acids research 46 (4), 1584-1600, 2018 | 597 | 2018 |
| Inhibition of human telomerase activity by peptide nucleic acids JC Norton, MA Piatyszek, WE Wright, JW Shay, DR Corey Nature biotechnology 14 (5), 615-619, 1996 | 574 | 1996 |
| Novel antisense and peptide nucleic acid strategies for controlling gene expression DA Braasch, DR Corey Biochemistry 41 (14), 4503-4510, 2002 | 512 | 2002 |
| Regulation of TFEB and V‐ATPases by mTORC1 S Peña‐Llopis, S Vega‐Rubin‐de‐Celis, JC Schwartz, NC Wolff, ... The EMBO journal 30 (16), 3242-3258, 2011 | 480 | 2011 |
| Silencing disease genes in the laboratory and the clinic JK Watts, DR Corey The Journal of pathology 226 (2), 365-379, 2012 | 437 | 2012 |
| Involvement of AGO1 and AGO2 in mammalian transcriptional silencing BA Janowski, KE Huffman, JC Schwartz, R Ram, R Nordsell, DS Shames, ... Nature structural & molecular biology 13 (9), 787-792, 2006 | 419 | 2006 |
| RNA sequencing: platform selection, experimental design, and data interpretation Y Chu, DR Corey Nucleic acid therapeutics 22 (4), 271-274, 2012 | 409 | 2012 |
| Chemical modification: the key to clinical application of RNA interference? DR Corey The Journal of clinical investigation 117 (12), 3615-3622, 2007 | 398 | 2007 |
| RNAi factors are present and active in human cell nuclei KT Gagnon, L Li, Y Chu, BA Janowski, DR Corey Cell reports 6 (1), 211-221, 2014 | 397 | 2014 |
| Generation of a hybrid sequence-specific single-stranded deoxyribonuclease DR Corey, PG Schultz Science 238 (4832), 1401-1403, 1987 | 366 | 1987 |
| Antisense transcripts are targets for activating small RNAs JC Schwartz, ST Younger, NB Nguyen, DB Hardy, BP Monia, DR Corey, ... Nature structural & molecular biology 15 (8), 842-848, 2008 | 353 | 2008 |
| Biodistribution of phosphodiester and phosphorothioate siRNA DA Braasch, Z Paroo, A Constantinescu, G Ren, OK Öz, RP Mason, ... Bioorganic & medicinal chemistry letters 14 (5), 1139-1143, 2004 | 351 | 2004 |
| Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-κB activation of cyclooxygenase 2 expression DB Hardy, BA Janowski, DR Corey, CR Mendelson Molecular endocrinology 20 (11), 2724-2733, 2006 | 329 | 2006 |
| Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression D Yu, H Pendergraff, J Liu, HB Kordasiewicz, DW Cleveland, EE Swayze, ... Cell 150 (5), 895-908, 2012 | 324 | 2012 |
| Morpholino antisense oligonucleotides: tools for investigating vertebrate development DR Corey, JM Abrams Genome biology 2, 1-3, 2001 | 324 | 2001 |
